Nexus Surgical & Medicare Complete Financial Statements
In FYNone, Nexus Surgical & Medicare (NEXUSSURGL) reported revenue ₹7 Cr, net profit ₹1 Cr and EPS ₹1.10, with a net profit margin of 16.7% and ROE of 100.0%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see NEXUSSURGL company profile.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
NEXUSSURGL Revenue, Net Profit & EBITDA — Year-on-Year Growth
NEXUSSURGL YoY (March 2025 vs Period) — revenue +16.7%, expenses +40.0%.
NEXUSSURGL Income Statement — Revenue, EBITDA & Net Profit
Nexus Surgical & Medicare revenue ₹7 Cr, EBITDA ₹1 Cr, net profit ₹1 Cr, EPS ₹1.10 (None) — net profit margin 16.7%. Explore Nexus Surgical & Medicare intrinsic worth to estimate fundamental worth using multiple valuation models.
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7 | 6 | 4 | 2 | 2 | 4 | 2 | 2 | 1 | 0 | 0 | 0 |
| Expenses | 7 | 5 | 3 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 0 | 0 |
| EBITDA | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit Margin % | 12.00% | 12.00% | 8.00% | 14.00% | 15.00% | 4.00% | 4.00% | -8.00% | -39.00% | -62.00% | 23.00% | 50.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 0 | 0 | 0 | 0 | -5 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 0 | 0 | 0 | 0 | -5 | 0 | 0 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 1.10 | 0.91 | 0.39 | 0.31 | 0.53 | 0.28 | -9.68 | -0.20 | -0.60 | -0.35 | 0.09 | 0.27 |
NEXUSSURGL Balance Sheet — Assets, Liabilities & Shareholders' Equity
NEXUSSURGL total assets ₹2 Cr, total equity ₹1 Cr, total liabilities ₹ Cr (2025) — ROE 100.0%.
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 2 | 2 | 1 | 2 | 1 | 0 | 6 | 6 | 6 | 6 | 6 |
| Current Assets | 2 | 2 | 1 | 2 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 5 | 5 | 5 | 5 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 2 | 2 | 1 | 2 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
| LIABILITIES | |||||||||||
| Total Liabilities | |||||||||||
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 1 | 1 | 0 | 0 | 0 | 0 | 5 | 5 | 6 | 6 | 6 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | -4 | -5 | -5 | -5 | -6 | -6 | 0 | 0 | 0 | 0 | 0 |
NEXUSSURGL Cash Flow Statement — Operating, Investing & Financing
Nexus Surgical & Medicare operating cash flow ₹0 Cr, investing ₹0 Cr, financing ₹0 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |